Quantitative proteomics analysis of differentially expressed proteins in activated B-cell-like diffuse large B-cell lymphoma using quantitative proteomics-Reference-Cited by-同舟云学术

Quantitative proteomics analysis of differentially expressed proteins in activated B-cell-like diffuse large B-cell lymphoma using quantitative proteomics

Published:2019-09 Issue:9 Volume:215 Page:152528
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Gao Hai-Xia,Nuerlan Aijiang,Abulajiang Gulinaer,Cui Wen-Li,Xue Jing,Sang Wei,Li Si-Jing,Niu Jing,Ma Zhi-Ping,Zhang Wei,Li Xin-Xia

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference45 articles.

1. Diffuse large B-cell lymphoma-treatment approaches in the molecular era, nature reviews;Roschewski;Clin. Oncol.,2014

2. Advances in diagnosis and management of diffuse large B-cell lymphoma;Cabanillas;Clin. Lymphoma Myeloma Leuk.,2017

3. The GCB subtype of diffuse large B-cell lymphoma is less frequent in Asian countries;Shiozawa;Leuk. Res.,2007

4. Diffuse large B-cell lymphoma: R-CHOP failure-what to do?;Coiffier;Hematol. Am. Soc. Hematol. Educ. Program,2016

5. Aggressive lymphomas;Georg;N. Engl. J. Med.,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in proteomics in diffuse large B‑cell lymphoma (Review);Oncology Reports;2024-05-09

2. Proteomics Identifies Circulating TIMP-1 as a Prognostic Biomarker for Diffuse Large B-Cell Lymphoma;Molecular & Cellular Proteomics;2023-09

3. Meta-Analysis of MS-Based Proteomics Studies Indicates Interferon Regulatory Factor 4 and Nucleobindin1 as Potential Prognostic and Drug Resistance Biomarkers in Diffuse Large B Cell Lymphoma;Cells;2023-01-03

4. Expression of PD-L1 and YWHAZ in Patients with Diffuse Large B Cell Lymphoma: A Possible Association with the Prognosis of Lymphoma;Journal of Immunology Research;2022-09-28

5. hsa-MicroRNA-28-5p Inhibits Diffuse Large B-Cell Lymphoma Cell Proliferation by Downregulating 14-3-3ζ Expression;Evidence-Based Complementary and Alternative Medicine;2022-01-04